Granite Point Capital

Granite Point Capital is a hedge fund. They have closed-end investment office in Boston, MA. Jeffrey Barnett, the chief operating officer

Business Model:

Revenue: $27.2M

Employees: 51-200

Rankings

Detailed Granite Point Capital Information

Geographic Data

Granite Point Capital headquarters map

Address: 222 Berkeley St

City: Boston

State: MA

Zip: 02116

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$93M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Granite Point Capital is a hedge fund. They have closed-end investment office in Boston, MA. Jeffrey Barnett, the chief operating officer of Granite Point Capital in Boston, is responsible for all aspects of the firm&s;s business, including human resources, systems, trading, compliance and risk management. He also serves on the firm&s;s investment committee, and has been instrumental in crafting a number of its investments in private equity transactions. Launched in February of 2004, Granite Point Capital is a research-driven, long/short equity hedge fund with a global mandate and a focus on mid-small cap US equities. Although primarily focused on the public markets, it has invested in a number of PIPEs, private equity and venture-backed companies.

Contact Phone:
+16175877507

Contact Email:

Announced Date Company Transaction Money Raised
10/2018 Teikametrics Series A 10M
6/2018 Cerebral Therapeutics Series A 3M
1/2020 Cerebral Therapeutics Series B 35M
2/2020 Teikametrics Equity 15M
7/2021 Teikametrics Series B 0
11/2021 Antios Therapeutics Series B 0
5/2016 Cyber adAPT Series A 0
4/2021 Antios Therapeutics Series B 0
10/2009 Health Guru Media Inc. Series C 3.2M
3/2019 Cerebral Therapeutics Series A 7.8M
4/2022 Receptor Life Sciences Series A 9.7M
6/2022 Cerebral Therapeutics Series C 40M
9/2017 Engage Therapeutics Series A 23.6M
6/2022 Cerebral Therapeutics Series C 0
4/2022 Receptor Life Sciences Series A 0
11/2021 Antios Therapeutics Series B 0
7/2021 Teikametrics Series B 0
4/2021 Antios Therapeutics Series B 0
2/2020 Teikametrics Venture Round 0
1/2020 Cerebral Therapeutics Series B 0
3/2019 Cerebral Therapeutics Series A 0
10/2018 Teikametrics Series A 0
6/2018 Cerebral Therapeutics Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research